Not investment advice. Educational platform. See Disclaimer.
NASDAQ: RGEN
Repligen Corporation
Healthcare | Medical - Instruments & Supplies
No licensed closing price on file for RGEN. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (FY2025)$0.86
Repligen Corporation (NASDAQ: RGEN) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-19 15:45 UTC.
2026-09-15Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-09-02Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-06-14Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
Repligen Corporation is a medical instruments and supplies company, listed on NASDAQ as RGEN.
When did RGEN last file with the SEC?
Repligen Corporation's most recent SEC filing on record is a 8-K filed 2026-05-15. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-19 15:45 UTC. This page is also available as JSON at /api/data?ticker=RGEN and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for RGEN and 5,000+ tickers.
Oxford Ledge
Search